Search results
Doctors excited about targeted prostate cancer therapy, but can't prescribe it yet
The Canadian Press via Yahoo Finance Canada· 4 days ago"(The doctor) said, 'Do you see any difference?'" the 79-year-old from Petrolia, Ont., recalled. "I...
Acquitted of murder, Nadler sues Hawkesbury hospital, faces own lawsuit from patient's family
Ottawa Citizen· 5 days agoBrian Nadler, the former Hawkesbury doctor acquitted this week of four counts of first-degree...
Charles River (CRL) Teams Up to Aid Stargardt's Disease Therapy
Zacks via Yahoo Finance Canada· 15 hours agoHIMS’ earnings beat estimates in three of the trailing four quarters and missed in one, delivering...
Eli Lilly to buy bowel disease drug developer Morphic for US$3.2-billion
The Globe and Mail· 2 days agoShares of drug developer...cent to $56.15 premarket on Lilly’s offer of $57 per share, which...
Middlemen have outsized influence on US drug prices, FTC says
Reuters via Yahoo Finance Canada· 16 hours agoFederal Trade Commission said on Tuesday. The FTC argues the three biggest PBMs - managing 79% of...
Dr. Brian Nadler fires back at Hawkesbury Hospital, staff with $20M lawsuit
CBC via Yahoo Canada News· 6 days agoDr. Brian Nadler, the physician acquitted this week of first-degree murder and criminal negligence...
Apellis' (APLS) Syfovre Boost Sales, Regulatory Setbacks a Woe
Zacks via Yahoo Finance Canada· 5 days agoApellis' (APLS) revenues rise on the back of the robust uptake of Syfovre for the GA indication....
Alcon (ALC) Inks Buyout Deal to Expand Its Glaucoma Portfolio
Zacks via Yahoo Finance Canada· 5 days agoAlcon (ALC) announces the closing of its deal to acquire BELKIN Vision. Per the terms of the...
Abortion rights measure files more than double the signatures to appear on the November ballot
Arizona Mirror· 6 days agoArizona’s abortion rights initiative is one step away from being considered by voters in the fall,...
Henry Schein (HSIC) Banks on Strategic Buyouts Amid Macro Issues
Zacks via Yahoo Finance Canada· 5 days agoEstimates for the company’s earnings have moved north by 11.1% to 20 cents for 2024 in the past 30...